BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25779363)

  • 1. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
    Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
    Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.
    Chung EJ; Jeong WJ; Jung YH; Kwon SK; Kwon TK; Ahn SH; Sung MW; Keam B; Heo DS; Kim JH; Wu HG; Lee KW; Eom KY; Rho YS
    Oral Oncol; 2019 Feb; 89():84-94. PubMed ID: 30732965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
    Li ZD; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
    [No Abstract]   [Full Text] [Related]  

  • 4. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic and functional outcomes in advanced laryngeal and hypopharyngeal cancer treated with concurrent chemoradiation versus primary surgery followed by adjuvant treatment.
    Jantharapattana K
    J Med Assoc Thai; 2013 Sep; 96(9):1164-8. PubMed ID: 24163992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
    Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
    Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
    Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
    Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
    Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
    Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
    Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Survival Outcomes Between Larynx-Preserving Open Partial Pharyngectomy and Radiotherapy or Chemoradiotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Single-Center Retrospective Analysis with Inverse Probability of Treatment Weighting Adjustments.
    Eguchi K; Omura G; Murakami N; Honma Y; Yokoyama K; Watanabe T; Aihara Y; Sakai A; Matsumoto Y; Sakai T; Kobayashi K; Igaki H; Yoshimoto S
    Ann Surg Oncol; 2023 Oct; 30(11):6867-6874. PubMed ID: 37452169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?
    Sobrevilla-Moreno N; Altamirano-Garcia JI; Granados-Garcia M; Garcilazo-Reyes A; Herrera-Martinez M; Alvarez-Avitia MA
    Oncology (Williston Park); 2020 Jun; 34(6):211-215. PubMed ID: 32609868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma.
    Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
    JAMA Netw Open; 2022 Feb; 5(2):e220165. PubMed ID: 35191967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
    Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.
    Sittitrai P; Reunmarkkaew D; Chaiyasate S
    J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):62. PubMed ID: 30326958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.